Adhesions
Conditions
Keywords
Surgery, Colectomy, Proctocolectomy, Adhesions
Brief summary
Study to investigate and determine the difference between the extent and severity of intra-abdominal adhesions in patients where SurgiWrap film was placed compared to patients with no adhesion barrier inserted. Hypothesis: Due to the preclinical safety data and clinical case reports in various indications it is anticipated that the surgical sites where the resorbable anti-adhesion barrier SurgiWrap was placed, there will be a reduction of adhesions compared to the control group with no treatment.
Interventions
SurgiWrapTM bioresorbable sheet will be secured directly below the abdominal incision.
Sponsors
Study design
Eligibility
Inclusion criteria
* Patients with rectal cancer, ulcerative colitis or other pathologies requiring a second surgery for ileostomy closure. * Age between 18 and 78 years. * Patient or his/her legal representative has read and signed the approved Informed Consent form before randomization.
Exclusion criteria
* Previous abdominal operation through a midline approach * Use of hernia mesh * Use of any antiadhesive irrigants or irrigants containing corticosteroids, heparin, salicylates, nonsteroidal anti-inflammatory drugs. * Pregnancy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Assess the extent and severity of new formed adhesions having its source in the target region where the SurgiWrap film initially was placed: between the midline incision/scar and the omentum, and between the midline incision/scar and the small bowel | 6 to 8 months |
Countries
Norway